轉(zhuǎn)甲狀腺素蛋白(PALB)單克隆抗體(生物素標(biāo)記)
Biotin-Linked Monoclonal Antibody to Prealbumin (PALB)
TBPA; PA; PLB; ATTR; TTR; Transthyretin; Prealbumin Amyloidosis Type I; Transports Thyroxine and Retinol
- 編號ULAA726Hu72
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源抗體標(biāo)記
- Ig亞型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物生物素
- 原抗體 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度1mg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC.
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 332 ¥ 775 ¥ 1107 ¥ 2768 ¥ 11070
- 欲了解實(shí)際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對PALB的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗中能識別PALB。
用法
免疫印跡：0.2-2μg/mL;1:500-5000
免疫組織化學(xué)：5-20μg/mL;1:50-200
免疫細(xì)胞化學(xué)：5-20μg/mL;1:50-200
最佳稀釋倍數(shù)最終由用戶決定。
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPA726Hu02 | 轉(zhuǎn)甲狀腺素蛋白(PALB)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA726Hu01 | 轉(zhuǎn)甲狀腺素蛋白(PALB)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAA726Hu01 | 轉(zhuǎn)甲狀腺素蛋白(PALB)多克隆抗體 | WB; IHC |
| UPAA726Hu02 | 轉(zhuǎn)甲狀腺素蛋白(PALB)多克隆抗體 | WB; IHC; ICC; IP. |
| ULAA726Hu81 | 轉(zhuǎn)甲狀腺素蛋白(PALB)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| ULAA726Hu71 | 轉(zhuǎn)甲狀腺素蛋白(PALB)多克隆抗體(生物素標(biāo)記) | IHC |
| UMAA726Hu21 | 轉(zhuǎn)甲狀腺素蛋白(PALB)單克隆抗體 | WB |
| UMAA726Hu23 | 轉(zhuǎn)甲狀腺素蛋白(PALB)單克隆抗體 | WB |
| UMAA726Hu24 | 轉(zhuǎn)甲狀腺素蛋白(PALB)單克隆抗體 | WB; IHC |
| UMAA726Hu22 | 轉(zhuǎn)甲狀腺素蛋白(PALB)單克隆抗體 | WB |
| UFAA726Hu02 | 抗轉(zhuǎn)甲狀腺素蛋白(PALB)單克隆抗體 | FCM |
| ULAA726Hu82 | 轉(zhuǎn)甲狀腺素蛋白(PALB)單克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| ULAA726Hu72 | 轉(zhuǎn)甲狀腺素蛋白(PALB)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| USEA726Hu | 轉(zhuǎn)甲狀腺素蛋白(PALB)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCA726Hu | 轉(zhuǎn)甲狀腺素蛋白(PALB)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMA726Hu | 轉(zhuǎn)甲狀腺素蛋白(PALB)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UKSA726Hu01 | 轉(zhuǎn)甲狀腺素蛋白(PALB)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Chinese Medical Journal | Screening disease-associated proteins from sera of patients with rheumatoid arthritis: a comparative proteomic study [PubMed: 20367977] |
| Journal of Vascular Surgery | Circulation levels of acute phase proteins in patients with Takayasu arteritis [PubMed: 20100644] |
| Journal of Pharmaceutical and Biomedical Analysis | Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2 [PubMed: 21130593] |
| Toxicology Letters | Serum proteomic analysis reveals potential serum biomarkers for occupational medicamentosa-like dermatitis caused by trichloroethylene [Pubmed:24960064] |
| Journal of Neurochemistry | Schwann cells contribute to neurodegeneration in transthyretin amyloidosis [Pubmed:25693163] |
| Anal Biochem | Surface plasmon resonance assay of inhibition by pharmaceuticals for thyroxine hormone binging to transport proteins [PubMed: 26384643] |
| United States Patent Application | Compositions and Methods for Diagnosing Lung Cancer [y2016:0077095.html] |
| Neurotherapeutics | iTRAQ-Based Quantitative Proteomics Reveals the New Evidence Base for Traumatic Brain Injury Treated with Targeted Temperature Management [pubmed:29247448] |
| Neuroimmunomodulation | CD4+ T Cells Affect the Thyroid Hormone Transport at the Choroid Plexus in Mice Raised in Enriched Environment [Pubmed: 30703773] |
| Diagnostics | Systemic Alterations of Immune Response-Related Proteins during Glaucoma Development in the Murine Model DBA/2J [Pubmed: 32585848] |
| Circulation-Genomic and Precision Medicine | Primary Cardiac Involvement in the Rare Transthyretin Ile73Val Mutation: A Case Series [Pubmed: 32393063] |
留言咨詢
